These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 4413070)

  • 21. Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):37-50. PubMed ID: 4153090
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of binding in inhibition of hepatic microsomal metabolism by parathion and malathion.
    Stevens JT
    Life Sci; 1974 Jun; 14(11):2215-29. PubMed ID: 4847813
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective stimulation by urethan of hepatic microsomal aniline hydroxylation.
    Schenkman JB; Ritchie A; Cha YN; Sartorelli AC
    Biochem Pharmacol; 1974 Mar; 23(6):1148-51. PubMed ID: 4824915
    [No Abstract]   [Full Text] [Related]  

  • 24. The nature of the reverse type I (modified type II) spectral change in liver microsomes.
    Schenkman JB; Cinti DL; Orrenius S; Moldeus P; Kraschnitz R
    Biochemistry; 1972 Nov; 11(23):4243-51. PubMed ID: 5079897
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of various barbiturates on hepatic microsomal enzymes. A comparative study.
    Valerino DM; Vesell ES; Aurori KC; Johnson AO
    Drug Metab Dispos; 1974; 2(5):448-57. PubMed ID: 4156308
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of GPA 1851 on hepatic microsomal drug metabolism dependent on dosage and time of sacrifice.
    Vessell ES; Lee CJ; Passananti GT; Shively CA
    Pharmacology; 1972; 8(4):217-21. PubMed ID: 4657973
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of various centrally active drugs on hepatic microsomal enzymes: a comparative study.
    Valerino DM; Vesell ES; Johnson AO; Aurori KC
    Drug Metab Dispos; 1973; 1(5):669-78. PubMed ID: 4149705
    [No Abstract]   [Full Text] [Related]  

  • 29. Human liver microsomal drug metabolism.
    Darby FJ; Newnes W; Price Evans DA
    Biochem Pharmacol; 1970 Apr; 19(4):1514-7. PubMed ID: 4398013
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of cytochrome P-448 mixed function oxidase activity following administration of 9-hydroxyellipticine to rats.
    Delaforge M; Ioannides C; Parke DV
    Chem Biol Interact; 1980 Oct; 32(1-2):101-10. PubMed ID: 7428105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.
    Cinti DL; Moldeus P; Schenkman JB
    Biochem Pharmacol; 1972 Dec; 21(24):3249-56. PubMed ID: 4405367
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of manganese on the hepatic microsomal mixed function oxidase enzyme system in the rat.
    Deimling MJ; Schnell RC
    Fundam Appl Toxicol; 1984 Dec; 4(6):1009-18. PubMed ID: 6519370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of drug metabolizing enzymes by diazepam in rat liver.
    Vorne M; Idänpään-Heikkilä J
    Experientia; 1975 Aug; 31(8):962-3. PubMed ID: 1157872
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of ethoxyquin on the carbon tetrachloride-induced changes in rat hepatic microsomal enzymes.
    Cawthorne MA; Palmer ED; Green J
    Biochem Pharmacol; 1973 Aug; 22(16):2066-8. PubMed ID: 4353671
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of the effect of acute ethanol on hexobarbital metabolism.
    Chung H; Brown DR
    Biochem Pharmacol; 1976 Jul; 25(14):1613-6. PubMed ID: 942461
    [No Abstract]   [Full Text] [Related]  

  • 36. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 37. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for spironolactone as a possible inducer of liver microsomal enzymes in mice.
    Gerald MC; Feller DR
    Biochem Pharmacol; 1970 Aug; 19(8):2529-32. PubMed ID: 5520611
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth hormone and drug metabolism. Acute effects on microsomal mixed-function oxidase activities in rat liver.
    Wilson JT; Spelsberg TC
    Biochem J; 1976 Feb; 154(2):433-8. PubMed ID: 938458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effect of pyrazinamide on microsomal monooxygenase activities is related to the binding to reduced cytochrome P-450.
    Maffei Facino R; Carini M
    Pharmacol Res Commun; 1980 Jun; 12(6):523-37. PubMed ID: 7403228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.